
Amanda Marie Haney
Examiner (ID: 4279, Phone: (571)272-8668 , Office: P/1634 )
| Most Active Art Unit | 1634 |
| Art Unit(s) | 1634, 1682 |
| Total Applications | 1000 |
| Issued Applications | 285 |
| Pending Applications | 140 |
| Abandoned Applications | 613 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18666578
[patent_doc_number] => 11773456
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-03
[patent_title] => Loop-mediated isothermal amplification (LAMP) primer sets for detecting porcine susceptibility-related pathogenic bacteria, and kit, LAMP chip and use based on the same
[patent_app_type] => utility
[patent_app_number] => 17/820601
[patent_app_country] => US
[patent_app_date] => 2022-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 15
[patent_no_of_words] => 7293
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 575
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17820601
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/820601 | Loop-mediated isothermal amplification (LAMP) primer sets for detecting porcine susceptibility-related pathogenic bacteria, and kit, LAMP chip and use based on the same | Aug 17, 2022 | Issued |
Array
(
[id] => 18511727
[patent_doc_number] => 20230227914
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-20
[patent_title] => BIOMARKERS OF ORAL, PHARYNGEAL AND LARYNGEAL CANCERS
[patent_app_type] => utility
[patent_app_number] => 17/888290
[patent_app_country] => US
[patent_app_date] => 2022-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13198
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17888290
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/888290 | BIOMARKERS OF ORAL, PHARYNGEAL AND LARYNGEAL CANCERS | Aug 14, 2022 | Abandoned |
Array
(
[id] => 18093514
[patent_doc_number] => 20220411855
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-29
[patent_title] => PORTABLE, LOW-COST PATHOGEN DETECTION AND STRAIN IDENTIFICATION PLATFORM
[patent_app_type] => utility
[patent_app_number] => 17/849250
[patent_app_country] => US
[patent_app_date] => 2022-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25521
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17849250
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/849250 | Portable, low-cost pathogen detection and strain identification platform | Jun 23, 2022 | Issued |
Array
(
[id] => 19210954
[patent_doc_number] => 12000004
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-06-04
[patent_title] => Methods for molecularly characterizing cervical cell samples
[patent_app_type] => utility
[patent_app_number] => 17/839803
[patent_app_country] => US
[patent_app_date] => 2022-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 34
[patent_no_of_words] => 12693
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 201
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17839803
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/839803 | Methods for molecularly characterizing cervical cell samples | Jun 13, 2022 | Issued |
Array
(
[id] => 17883079
[patent_doc_number] => 20220298556
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-22
[patent_title] => PIRNA-54265 DETECTION KIT USED FOR EARLY SCREENING, DIAGNOSIS, CURATIVE EFFICACY MONITORING AND PROGNOSTIC EVALUATION OF COLORECTAL CANCER
[patent_app_type] => utility
[patent_app_number] => 17/830354
[patent_app_country] => US
[patent_app_date] => 2022-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10533
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 116
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17830354
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/830354 | PIRNA-54265 detection kit used for early screening, diagnosis, curative efficacy monitoring and prognostic evaluation of colorectal cancer | Jun 1, 2022 | Issued |
Array
(
[id] => 17838158
[patent_doc_number] => 20220275463
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-01
[patent_title] => STRATIFICATION AND PROGNOSIS OF CANCER
[patent_app_type] => utility
[patent_app_number] => 17/751038
[patent_app_country] => US
[patent_app_date] => 2022-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17735
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17751038
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/751038 | STRATIFICATION AND PROGNOSIS OF CANCER | May 22, 2022 | Abandoned |
Array
(
[id] => 18909267
[patent_doc_number] => 11872230
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-16
[patent_title] => Method of treating a methionine-dependent cancer
[patent_app_type] => utility
[patent_app_number] => 17/745292
[patent_app_country] => US
[patent_app_date] => 2022-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 64
[patent_figures_cnt] => 64
[patent_no_of_words] => 22701
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17745292
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/745292 | Method of treating a methionine-dependent cancer | May 15, 2022 | Issued |
Array
(
[id] => 17838929
[patent_doc_number] => 20220276234
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-01
[patent_title] => POINT-OF-CARE IMMUNOASSAY FOR QUANTITATIVE SMALL ANALYTE DETECTION
[patent_app_type] => utility
[patent_app_number] => 17/739731
[patent_app_country] => US
[patent_app_date] => 2022-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23191
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17739731
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/739731 | POINT-OF-CARE IMMUNOASSAY FOR QUANTITATIVE SMALL ANALYTE DETECTION | May 8, 2022 | Pending |
Array
(
[id] => 17990484
[patent_doc_number] => 20220356521
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-10
[patent_title] => METHODS FOR DETECTING, MONITORING, AND GUIDING TREATMENT OF ALLOGRAFT REJECTION USING DISCRIMINATING GENE EXPRESSION SIGNATURES
[patent_app_type] => utility
[patent_app_number] => 17/733762
[patent_app_country] => US
[patent_app_date] => 2022-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44987
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17733762
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/733762 | METHODS FOR DETECTING, MONITORING, AND GUIDING TREATMENT OF ALLOGRAFT REJECTION USING DISCRIMINATING GENE EXPRESSION SIGNATURES | Apr 28, 2022 | Pending |
Array
(
[id] => 18764301
[patent_doc_number] => 11814688
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-11-14
[patent_title] => Markers for determining tumor hypoxia
[patent_app_type] => utility
[patent_app_number] => 17/728506
[patent_app_country] => US
[patent_app_date] => 2022-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 15
[patent_no_of_words] => 19739
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 153
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17728506
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/728506 | Markers for determining tumor hypoxia | Apr 24, 2022 | Issued |
Array
(
[id] => 17990493
[patent_doc_number] => 20220356530
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-10
[patent_title] => METHODS FOR DETERMINING VELOCITY OF TUMOR GROWTH
[patent_app_type] => utility
[patent_app_number] => 17/725341
[patent_app_country] => US
[patent_app_date] => 2022-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 82982
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 272
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17725341
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/725341 | METHODS FOR DETERMINING VELOCITY OF TUMOR GROWTH | Apr 19, 2022 | Pending |
Array
(
[id] => 17830558
[patent_doc_number] => 20220267862
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-25
[patent_title] => DNA METHYLATION SIGNATURES OF CANCER IN HOST PERIPHERAL BLOOD MONONUCLEAR CELLS AND T CELLS
[patent_app_type] => utility
[patent_app_number] => 17/700702
[patent_app_country] => US
[patent_app_date] => 2022-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18182
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 416
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17700702
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/700702 | DNA METHYLATION SIGNATURES OF CANCER IN HOST PERIPHERAL BLOOD MONONUCLEAR CELLS AND T CELLS | Mar 21, 2022 | Pending |
Array
(
[id] => 20173251
[patent_doc_number] => 12391985
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-08-19
[patent_title] => Method of determining
[patent_app_type] => utility
[patent_app_number] => 17/699761
[patent_app_country] => US
[patent_app_date] => 2022-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 18
[patent_no_of_words] => 8892
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 307
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17699761
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/699761 | Method of determining | Mar 20, 2022 | Issued |
Array
(
[id] => 18077855
[patent_doc_number] => 20220403467
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-22
[patent_title] => DETERMINING CELL TYPE ORIGIN OF CIRCULATING CELL-FREE DNA WITH MOLECULAR COUNTING
[patent_app_type] => utility
[patent_app_number] => 17/682759
[patent_app_country] => US
[patent_app_date] => 2022-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3119
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17682759
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/682759 | DETERMINING CELL TYPE ORIGIN OF CIRCULATING CELL-FREE DNA WITH MOLECULAR COUNTING | Feb 27, 2022 | Pending |
Array
(
[id] => 17735923
[patent_doc_number] => 20220221382
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-14
[patent_title] => METHOD OF POOLING BLOOD SAMPLES
[patent_app_type] => utility
[patent_app_number] => 17/652172
[patent_app_country] => US
[patent_app_date] => 2022-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14244
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 137
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17652172
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/652172 | METHOD OF POOLING BLOOD SAMPLES | Feb 22, 2022 | Pending |
Array
(
[id] => 17830556
[patent_doc_number] => 20220267860
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-25
[patent_title] => LONGITUDINAL MOLECULAR DIAGNOSTICS DETECT SOMATIC REVERSION MUTATIONS
[patent_app_type] => utility
[patent_app_number] => 17/651793
[patent_app_country] => US
[patent_app_date] => 2022-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12332
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 221
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17651793
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/651793 | LONGITUDINAL MOLECULAR DIAGNOSTICS DETECT SOMATIC REVERSION MUTATIONS | Feb 18, 2022 | Abandoned |
Array
(
[id] => 17750872
[patent_doc_number] => 20220229077
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-21
[patent_title] => DIAGNOSIS, PROGNOSIS AND TREATMENT FOR SCHIZOPHRENIA AND SCHIZOAFFECTIVE PSYCHOSIS
[patent_app_type] => utility
[patent_app_number] => 17/651397
[patent_app_country] => US
[patent_app_date] => 2022-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38982
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17651397
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/651397 | DIAGNOSIS, PROGNOSIS AND TREATMENT FOR SCHIZOPHRENIA AND SCHIZOAFFECTIVE PSYCHOSIS | Feb 15, 2022 | Abandoned |
Array
(
[id] => 19210943
[patent_doc_number] => 11999993
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-06-04
[patent_title] => Use of biomarkers in identifying cancer patients that will be responsive to treatment with a PRMT5 inhibitor
[patent_app_type] => utility
[patent_app_number] => 17/669008
[patent_app_country] => US
[patent_app_date] => 2022-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10641
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17669008
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/669008 | Use of biomarkers in identifying cancer patients that will be responsive to treatment with a PRMT5 inhibitor | Feb 9, 2022 | Issued |
Array
(
[id] => 17792562
[patent_doc_number] => 20220251653
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-11
[patent_title] => Determining Antigen-Specific T-Cells
[patent_app_type] => utility
[patent_app_number] => 17/579900
[patent_app_country] => US
[patent_app_date] => 2022-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28526
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17579900
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/579900 | Determining antigen-specific T-cells | Jan 19, 2022 | Issued |
Array
(
[id] => 18844986
[patent_doc_number] => 20230407390
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-21
[patent_title] => NUCLEIC ACID AMPLIFICATION METHOD, PRIMER SET, PROBE, AND KIT FOR NUCLEIC ACID AMPLIFICATION METHOD
[patent_app_type] => utility
[patent_app_number] => 18/036524
[patent_app_country] => US
[patent_app_date] => 2021-12-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14647
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 366
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18036524
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/036524 | NUCLEIC ACID AMPLIFICATION METHOD, PRIMER SET, PROBE, AND KIT FOR NUCLEIC ACID AMPLIFICATION METHOD | Dec 23, 2021 | Pending |